RBC Capital Maintains Outperform on Aramark, Raises Price Target to $70
RBC Capital analyst Karl Green maintains Aramark (NYSE:ARMK) with a Outperform and raises the price target from $60 to $70.
Stocks · News reference
Cardinal Health, Babcock & Wilcox Enterprises and 3 Stocks to Watch Heading Into Tuesday
U.S. stock futures mixed, focus on Super Micro Computer Inc, Upwork Inc, Cardinal Health Inc, Babcock & Wilcox Enterprises Inc.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Citigroup Maintains Buy on Aramark, Raises Price Target to $74
Citigroup analyst Leo Carrington maintains Aramark (NYSE:ARMK) with a Buy and raises the price target from $70.5 to $74.
JP Morgan Maintains Overweight on Aramark, Raises Price Target to $70
JP Morgan analyst Andrew Steinerman maintains Aramark (NYSE:ARMK) with a Overweight and raises the price target from $55 to $70.
Stifel Maintains Buy on Aramark, Raises Price Target to $70
Stifel analyst Shlomo Rosenbaum maintains Aramark (NYSE:ARMK) with a Buy and raises the price target from $54 to $70.
Needham Initiates Coverage On Babcock & Wilcox with Buy Rating, Announces Price Target of $20
Needham analyst Sean Milligan initiates coverage on Babcock & Wilcox (NYSE:BW) with a Buy rating and announces Price Target of $20.
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield'
Jim Cramer likes Babcock & Wilcox and Smithfield Foods. He also advises taking some profits on BillionToOne, and calls Eton Pharma a winner.